| Name | Title | Contact Details |
|---|---|---|
John Kelly |
Chief Information Officer | Profile |
Since 2007, Dark Heart Nursery has specialized in cultivating high quality clones for growers across Northern California. Our years of experience allow us to bring you consistently premium clones from both popular and emerging genetic lines that will perform well in a variety of settings. We take pride in our work and continually adapt our process and selection to meet the diverse needs of growers large and small.
Well and Company™ is igniting a self care revolution, offering its community members a powerful opportunity to share daily strategies that confront significant health and lifestyle challenges including aging, weight gain, fatigue, sleeplessness, stress, and loneliness. We “Embrace the Day™,” through social selling with our engaging content, innovative products and inspired community.
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Elizabeth Township Medical Services is a Elizabeth, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Patient Focus Systems is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.